I have been a fan of Indigogo and Kickstarter for the last couple of years and have invested in some good products and some not-so-good products. I have a Twicycle (https://twicycle.com) and Ice Plate – The DIY At Home Ice Cream Roll Maker on its way. They also have a …

Why and when to use this therapy to treat patients who have type 2 diabetes.

Method to identify prediabetes found to impact risk of heart disease or death.

New research shows how estrogen treatment helps to control blood sugar levels after menopause.

Risk for stroke significantly increased, but exceeded by heart failure

Subanalysis of CANVAS program shows slower progression of kidney disease, reduction in weight, reduction in A1c and even drop in blood pressure.

Mr. Hernandez' lab results are A1C 7.5%, FPG 137 mg/dL, LDL 190 mg/dL, HDL 38 mg/DL and triglycerides 232 mg/dL. He is started on metformin, lifestyle modifications, an ACE inhibitor, and a statin. He was asked to return in 3 months' time to evaluate how everything is going. However, he fails to keep his appointment. He returns 1 year after his initial diagnosis for a recurrent yeast infection. His A1C is currently 7.7%. Upon questioning, he admits that while he has been good about taking his “heart meds,” he has not taken the “sugar pill” because he didn’t like it. What side effect did the patient most likely find intolerable? A. Diarrhea and abdominal cramping B. Paresthesias C. Increased appetite D. Insomnia Follow the link for the answer.

The American College of Physicians (ACP) has issued a new recommendation that type 2 patients should not have a target A1C level below 8 percent for any patient population and should not have any A1C targets for older adults (e.g., age 80 and older) or younger individuals with limited life expectancy because of other serious diseases and illnesses. Do you agree with the American College of Physicians' new A1C target recommendations? Follow the link to share your opinion.

Asymptomatic left ventricular systolic dysfunction patients with DM have higher risk than those without

Increased time in the near normoglycemic range and reduced time in hypo- and hyperglycemia